Please login to the form below

Not currently logged in
Email:
Password:

Electroporation delivery system wins bio-threat contract

US-based drug delivery company, Ichor Medical Systems, has been awarded a USD 2.3m contract to develop an electroporation DNA vaccine delivery system for anthrax and plague to counter bioterrorism

US-based drug delivery company, Ichor Medical Systems, has been awarded a USD 2.3m contract to develop an electroporation DNA vaccine delivery system for anthrax and plague to counter bioterrorism.

The two-year contract, which was awarded by the US Department of Defense's Defense Threat Reduction Agency (DTRA), will investigate the potential of electroporation-based drug delivery systems to increase the effectiveness of bio defence-related DNA vaccine candidates.
The administration of the vaccines would use Ichor's proprietary TriGrid electroporation delivery system, where a brief electrical pulse creates temporary openings in cell membranes through which medicines can enter the cell.

In preclinical studies, electroporation has been seen to increase the uptake of DNA-encoding vaccines and other gene-based therapies by up to as much as a 1,000 times compared with other delivery technologies.

Ichor's allows the delivery of DNA encoding vaccines and other gene-based therapies in one step to endogenously produce protein from the patient's own muscle. Other systems in use must inject the DNA first and then electrode needles are implanted manually into the tissue for activation. Ichor's TriGrid system combines the syringe needle and four electrodes in the same device.

The small hand-held device works by being held against the patient's upper arm. When a button is pushed the device deploys the needle and electrodes at a fixed depth and location and delivers the DNA drug and the electrical field to each patient in a consistent manner.

Ichor is involved in a number of pre-clinical and clinical studies exploring the potential treatment of diseases including atherosclerosis, avian flu, hepatitis B, HIV, melanoma, and multiple sclerosis.

In March 2007, Ichor was awarded a USD 900,000 contract by the US Department of Defense to assist the US Army in the development of a DNA vaccine for equine encephalitis.

9th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics